Analysts Viewpoint
Analysts pessimistic about ARWR’s future growth prospects
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Arrowhead Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Hamilton James C unloaded Company’s shares for reported $0.19 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Arrowhead Pharmaceuticals Inc revealed its Officer Myszkowski Kenneth Allen acquired Company’s shares for reported $0.76 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Arrowhead Pharmaceuticals Inc’s recently made public that its Officer Myszkowski Kenneth Allen acquired Company’s shares for reported $0.76 million on